# Epigenetix jobs and careers

> 0 open roles at Epigenetix as of October 24, 2026. Source: https://www.thejobsmap.com/company/epigenetix

Epigenetix is a clinical stage pharma company with a first-in-class oral cancer drug about to begin phase on trials at 5 leading US cancer centers. We will include patients with prostate cancer, pancreatic cancer, breast cancer, sarcoma, NUT carcinoma and other cancers where our drug has shown unprecedented anti-cancer activity. Our drug was selected among many other drug candidates to potently inhibit three different validated cancer drug targets: p300/CBP + BRD4+ CECR2. Treatment results in elimination of both the tumor itself as well as associated metastases. This powerful drug fights cancer in multiple ways: (1) by eradicating tumor cells directly (cytotoxic therapy), (2) by unleashing the body’s immune system (immunotherapy), and (3) by inhibiting cancer-inducing male and female hormone actions (hormone therapy). While presently pursued as monotherapy, synergy with checkpoint inhibitors, PARP inhibitors, CDK4/6 inhibitors as well as epigenetic drugs, such as EZH2 inhibitors ,has been shown preclinically.

## Key facts

| | |
|---|---|
| Open roles | 0 |
| Founded | 2011 |
| Employees | 1 to 10 |
| Industries | Biotechnology, Clinical Trials |
| Website | https://epigenetix.com |

## Leadership

- Joseph Collard, Cofounder CEO

## Common questions

### Is Epigenetix hiring right now?

Epigenetix has no open roles listed as of October 24, 2026. Roles appear here as soon as they are posted on Epigenetix's careers site.

### Who leads Epigenetix?

Joseph Collard, Cofounder CEO, is at the top of Epigenetix's org chart.

### How do I apply for a job at Epigenetix?

Pick a role on Epigenetix's TheJobsMap page and select Apply. Every listing links to the original posting on Epigenetix's own careers site, so you apply directly with the employer.